Physician profile
Barbara Ercole
NPI 1326231861
$2,341.66
in general payments reported to CMS, 2019-2025
21 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.91 · 2020: $236 · 2021: $272 · 2022: $421 · 2023: $412 · 2024: $505 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.32 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $323.70 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $288.22 | 2022-2025 | Myrisk, Prolaris |
| C. R. Bard, INC. & Subsidiaries | $266.20 | 2023-2025 | Bard Urinary Drainage Bag |
| Pfizer INC. | $247.77 | 2019-2022 | |
| Astellas Pharma US INC | $238.76 | 2020-2023 | Myrbetriq |
| Intuitive Surgical, INC. | $180.26 | 2020-2024 | |
| Becton, Dickinson and Company | $166.11 | 2024 | Bard Urinary Drainage Bag, Proxis Ureteral Access Sheath |
| Coloplast Corp | $124.88 | 2021-2024 | Speedicath |
| Koelis INC. | $107.06 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $70.77 | 2024-2025 | |
| Boston Scientific Corporation | $60.88 | 2020 | |
| Merck Sharp & Dohme LLC | $49.82 | 2022-2025 | Welireg, Keytruda |
| Abbvie INC. | $39.47 | 2023-2025 | |
| Urogen Pharma, INC. | $38.83 | 2023-2025 | Jelmyto |
| Procept Biorobotics Corporation | $24.17 | 2024 | Aquabeam System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $24.12 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $23.54 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $21.62 | 2022 | |
| Immunitybio, INC. | $16.85 | 2025 | |
| Olympus America INC. | $16.71 | 2020 | |
| Medtronic, INC. | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Ercole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.